vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and Nano Dimension Ltd. (NNDM). Click either name above to swap in a different company.

Bioceres Crop Solutions Corp. is the larger business by last-quarter revenue ($77.6M vs $57.8M, roughly 1.3× Nano Dimension Ltd.). Bioceres Crop Solutions Corp. runs the higher net margin — -9.6% vs -171.1%, a 161.5% gap on every dollar of revenue.

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

Nano Dimension Ltd. is a leading provider of additively manufactured electronics solutions and 3D printing technologies. It designs high-precision 3D printers, related materials, and software for producing printed circuit boards, microelectronics components, and multi-layer electronic devices, serving aerospace, defense, medical, automotive, and industrial electronics segments across global markets.

BIOX vs NNDM — Head-to-Head

Bigger by revenue
BIOX
BIOX
1.3× larger
BIOX
$77.6M
$57.8M
NNDM
Higher net margin
BIOX
BIOX
161.5% more per $
BIOX
-9.6%
-171.1%
NNDM

Income Statement — Q1 FY2026 vs Q4 FY2024

Metric
BIOX
BIOX
NNDM
NNDM
Revenue
$77.6M
$57.8M
Net Profit
$-7.4M
$-98.8M
Gross Margin
46.8%
43.1%
Operating Margin
9.3%
-155.1%
Net Margin
-9.6%
-171.1%
Revenue YoY
-16.8%
Net Profit YoY
-20.2%
EPS (diluted)
$-0.12
$-0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
NNDM
NNDM
Q3 25
$77.6M
Q1 25
$60.6M
Q4 24
$98.8M
$57.8M
Q3 24
$93.3M
Q2 24
$28.4M
Q1 24
$84.0M
Q4 23
$140.2M
Q3 23
$116.6M
Net Profit
BIOX
BIOX
NNDM
NNDM
Q3 25
$-7.4M
Q1 25
$-1.6M
Q4 24
$605.2K
$-98.8M
Q3 24
$-6.2M
Q2 24
$-79.2M
Q1 24
$9.8M
Q4 23
$1.2M
Q3 23
$-2.7M
Gross Margin
BIOX
BIOX
NNDM
NNDM
Q3 25
46.8%
Q1 25
39.4%
Q4 24
42.0%
43.1%
Q3 24
40.2%
Q2 24
45.8%
Q1 24
50.8%
Q4 23
36.7%
Q3 23
38.6%
Operating Margin
BIOX
BIOX
NNDM
NNDM
Q3 25
9.3%
Q1 25
1.5%
Q4 24
14.5%
-155.1%
Q3 24
2.5%
Q2 24
Q1 24
15.7%
Q4 23
12.0%
Q3 23
4.5%
Net Margin
BIOX
BIOX
NNDM
NNDM
Q3 25
-9.6%
Q1 25
-2.6%
Q4 24
0.6%
-171.1%
Q3 24
-6.6%
Q2 24
-279.4%
Q1 24
11.6%
Q4 23
0.9%
Q3 23
-2.3%
EPS (diluted)
BIOX
BIOX
NNDM
NNDM
Q3 25
$-0.12
Q1 25
$-0.02
Q4 24
$0.00
$-0.45
Q3 24
$-0.10
Q2 24
$-0.35
Q1 24
$0.14
Q4 23
$0.00
Q3 23
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
NNDM
NNDM
Cash + ST InvestmentsLiquidity on hand
$15.5M
$317.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$288.3M
$860.0M
Total Assets
$734.9M
$902.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
NNDM
NNDM
Q3 25
$15.5M
Q1 25
$38.5M
Q4 24
$29.2M
$317.2M
Q3 24
$32.3M
Q2 24
$231.8M
Q1 24
$16.4M
Q4 23
$24.4M
Q3 23
$28.4M
Stockholders' Equity
BIOX
BIOX
NNDM
NNDM
Q3 25
$288.3M
Q1 25
$345.0M
Q4 24
$346.3M
$860.0M
Q3 24
$346.0M
Q2 24
$870.3M
Q1 24
$348.5M
Q4 23
$335.3M
Q3 23
$332.6M
Total Assets
BIOX
BIOX
NNDM
NNDM
Q3 25
$734.9M
Q1 25
$798.2M
Q4 24
$835.2M
$902.5M
Q3 24
$827.3M
Q2 24
$911.0M
Q1 24
$836.1M
Q4 23
$819.5M
Q3 23
$819.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
NNDM
NNDM
Operating Cash FlowLast quarter
$14.4M
$-18.9M
Free Cash FlowOCF − Capex
$-21.1M
FCF MarginFCF / Revenue
-36.5%
Capex IntensityCapex / Revenue
3.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
NNDM
NNDM
Q3 25
$14.4M
Q1 25
$23.3M
Q4 24
$-5.4M
$-18.9M
Q3 24
$5.2M
Q2 24
$-30.7M
Q1 24
$-17.4M
Q4 23
$21.1M
Q3 23
$14.7M
Free Cash Flow
BIOX
BIOX
NNDM
NNDM
Q3 25
Q1 25
Q4 24
$-21.1M
Q3 24
Q2 24
Q1 24
Q4 23
Q3 23
FCF Margin
BIOX
BIOX
NNDM
NNDM
Q3 25
Q1 25
Q4 24
-36.5%
Q3 24
Q2 24
Q1 24
Q4 23
Q3 23
Capex Intensity
BIOX
BIOX
NNDM
NNDM
Q3 25
Q1 25
Q4 24
3.8%
Q3 24
Q2 24
Q1 24
Q4 23
Q3 23
Cash Conversion
BIOX
BIOX
NNDM
NNDM
Q3 25
Q1 25
Q4 24
-8.85×
Q3 24
Q2 24
Q1 24
-1.78×
Q4 23
17.05×
Q3 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons